Replies to post #54996 on Ariad Pharmaceuticals Inc fka ARIA

[gr8db8]

@BR Agree. Not a large population but frontline for 1000 patients per year (at $100K per year treatment) means $100 million. Not bad for ARIA. Hopefully, the patients live longer on Iclusig. We'll see.

[gr8db8]

@BR ... re "they do not live very long". Says here CML AP "4-year survival was 53%". If that's what you mean by not very long, then that's not bad at all. http://www.cancer.gov/cancertopics/pdq/treatment/CML/HealthProfessional/page5